BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 217218)

  • 1. A controlled study of the effect of sulfinpyrazone on platelet survival and on platelet-bound 14C-serotonin release in patients with previous myocardial infarction.
    Cortellaro M; Boschetti C; Fassio G; Basagni M; Polli EE
    Acta Haematol; 1979; 61(2):68-74. PubMed ID: 217218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled ex-vivo effect of sulfinpyrazone on platelet function of myocardial infarction patients.
    Cortellaro M; Fassio G; Boschetti C; Basagni M; Polli EE
    Haematologica; 1979 Apr; 64(2):173-89. PubMed ID: 112008
    [No Abstract]   [Full Text] [Related]  

  • 3. Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial.
    Anturane Reinfarction Trial Research Group
    N Engl J Med; 1978 Feb; 298(6):289-95. PubMed ID: 340942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo platelet hyperactivity and factor VIII related antigen increase long after myocardial infarction. A controlled effect of sulfinpyrazone.
    Cortellaro M; Boschetti C; Beggi P; Polli EE
    Scand J Haematol; 1981 Feb; 26(2):106-14. PubMed ID: 6454960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease.
    Steele P; Battock D; Genton E
    Circulation; 1975 Sep; 52(3):473-6. PubMed ID: 1157247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sulfinpyrazone on platelet prostaglandin synthesis and platelet release of serotonin.
    Ali M; McDonald JW
    J Lab Clin Med; 1977 Apr; 89(4):868-75. PubMed ID: 845486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulphinpyrazone in post-myocardial infarction. Report from the Anturan Reinfarction Italian Study.
    Lancet; 1982 Jan; 1(8266):237-42. PubMed ID: 6120272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfinpyrazone decreases epinephrine-induced platelet aggregation after myocardial infarction.
    Latour JG; Theroux P; Bourassa MG
    Am J Cardiol; 1982 Nov; 50(5):938-44. PubMed ID: 6753559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary prevention of myocardial infarction.
    Davies JA
    Int J Clin Pharmacol Res; 1985; 5(5):303-7. PubMed ID: 3905632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anturane reinfarction trial.
    Sherry S
    Circulation; 1980 Dec; 62(6 Pt 2):V73-8. PubMed ID: 7438382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sulfinpyrazone in the prevention of sudden death after myocardial infarction (author's transl)].
    Sherry S
    MMW Munch Med Wochenschr; 1980 Apr; 122(14):517-24. PubMed ID: 6769032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemostatic function changes in a trial on the secondary prevention of myocardial infarction with sulphinpyrazone.
    Cortellaro M; Boschetti C; Fassio G; Baroni L; Polli EE
    Acta Haematol; 1981; 65(3):193-204. PubMed ID: 6785974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets.
    Fabris F; Casonato A; Randi ML; Schivazappa L; Schiavinato L; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):594-601. PubMed ID: 6196274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anturane reinfarction trial.
    Evans DW
    Lancet; 1978 Aug; 2(8085):366-7. PubMed ID: 79725
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sulfinpyrazone (Anturan) after myocardial infarction].
    Faergeman O
    Ugeskr Laeger; 1980 Sep; 142(39):2571-2. PubMed ID: 7445168
    [No Abstract]   [Full Text] [Related]  

  • 16. Secondary prevention of myocardial infarction--the present state of the ART.
    Mitchell JR
    Br Med J; 1980 May; 280(6223):1128-30. PubMed ID: 7000236
    [No Abstract]   [Full Text] [Related]  

  • 17. A serial study of platelet reactivity throughout the first six months after myocardial infarction: its modification by sulphinpyrazone.
    Kubik MM; Richardson SG
    Postgrad Med J; 1987 May; 63(739):351-6. PubMed ID: 3118351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Platelet inhibitory agents in the prevention of infarct].
    Stormorken H
    Tidsskr Nor Laegeforen; 1978 Oct; 98(30):1523-4. PubMed ID: 725864
    [No Abstract]   [Full Text] [Related]  

  • 19. Sulphinpyrazone (Anturan) after myocardial infarct.
    Watt M
    N Z Med J; 1979 Oct; 90(646):352. PubMed ID: 392352
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interaction of sulfinpyrazone (Anturan) and glibenclamide (Euglucon) in type II diabetic patients].
    Kritz H; Najemnik C; Irsigler K
    Wien Med Wochenschr; 1983 May; 133(9):237-43. PubMed ID: 6408808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.